The outbreak of coronavirus and the infectious disease it causes (COVID-19) have taken different paths around the world, with countries experiencing different rates of infection, case prevalence and mortality.
To date, the field of health economics has been largely missing from this growing literature, yet it is an essential piece for evidence based decision-making. We discuss in this piece in which ways health economics can help decision-makers, and why health economics research and use needs to be scaled up.